Shigella dysenteriae
Shigella dysenteriae is a species of Gram-negative bacteria in the genus Shigella, which is responsible for causing dysentery. This bacterium is rod-shaped, non-motile, and does not form spores. It is a facultative anaerobe, meaning it can survive in both oxygen-rich and oxygen-poor environments.
Characteristics[edit]
Shigella dysenteriae is unique among the Shigella species due to its ability to produce Shiga toxin, a potent neurotoxin that can cause severe damage to the lining of the intestines and other tissues. This toxin is responsible for the severe symptoms associated with dysentery, including bloody diarrhea, abdominal pain, and fever.
Pathogenesis[edit]
Shigella dysenteriae is transmitted via the fecal-oral route, often through contaminated food or water. Once ingested, the bacteria invade the cells of the intestinal lining, causing inflammation and tissue damage. The bacteria can also spread to other parts of the body, causing systemic infection.
Treatment and Prevention[edit]
Treatment for Shigella dysenteriae infection typically involves rehydration and antibiotic therapy. However, some strains of the bacteria have developed resistance to common antibiotics, making treatment more difficult. Prevention of infection involves proper sanitation and hygiene practices, including handwashing and safe food handling.
Epidemiology[edit]
Shigella dysenteriae is most common in developing countries with poor sanitation and hygiene practices. Outbreaks often occur in crowded conditions, such as refugee camps or urban slums. However, the bacteria can also cause sporadic cases of dysentery in developed countries.
See Also[edit]
-
Dark field microscopy revealing Shigella dysenteriae bacteria
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian